News
Article
Author(s):
In case you missed it, this week we had news about the first FDA-approved gene therapy for RDEB, the influence of psoriasis on sun tanning addiction, and resources for Rosacea Awareness Month.
To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.
A new study reveals ongoing burden of moderate to severe atopic dermatitis in youth, with flares, comorbidities, and quality of life impacts.
Positive Correlation Between Acne and BMI in Adolescent Patients in Sudan
A new study reveals a significant link between acne prevalence and high BMI in Sudanese adolescents, highlighting gender differences and the need for further research.
Novel Serum Improves Facial Skin Quality in Patients Using GLP-1 Receptor Agonists
The groundbreaking GLPSGLT serum enhances skin quality for GLP-1 RA users, improving elasticity and reducing wrinkles in just 6 weeks.
Dermatology Times April 2025 Print Recap
Learn more about the in-depth topics covered in the April 2025 print issue of Dermatology Times.
Subgroup Case Series Reveals JAKi Efficacy for Black Patients With AA
JAK inhibitors show promise in treating alopecia areata among Black patients, highlighting the need for inclusive clinical research and equitable access to therapies.
FDA Approves First Gene Therapy for RDEB
The FDA approved pz-cel, a groundbreaking gene therapy for recessive dystrophic epidermolysis bullosa, transforming treatment options for patients.
Newly Developed Questionnaire Evaluates Quality of Life for Patients with Hair and Scalp Conditions
The innovative 21-item Hair & Scalp CARE questionnaire is designed to evaluate the psychological impact of hair and scalp conditions on quality of life.
Interview Intersection: Expert Interviews From April 2025
Dermatology Times is recapping our exclusive expert interviews from the month of April.
How Does Psoriasis Influence Sun Tanning Addiction?
Younger patients with moderate to severe psoriasis exhibit risky sun exposure behaviors, raising concerns about tanning addiction and skin cancer risks.
This review of the latest dermatologic studies includes insights into the environmental impact of dermatology, submicrobial dosing of antibiotics in dermatology, and more.
Top 5 Articles of the Month: April
Explore the top headlines of the week including insights on recalls, expert pearls, and more.
Dermatology Times April 2025 Recap
Dermatology Times is looking back on the top stories in dermatology from the month of April.
Celebrating Rosacea Awareness Month 2025 with Dermatology Times
Explore the latest insights, strategies, and treatments for patients with rosacea as Dermatology Times looks back on Rosacea Awareness Month.
JAKi and IL-4/-13i Show Similar Safety Profiles in AD
New research reveals JAK inhibitors for atopic dermatitis do not increase cardiovascular or cancer risks compared to IL-4/-13 inhibitors, offering reassurance for patients.
Q32 Bio’s Bempikibart Receives FDA Fast Track Designation for Alopecia Areata
The development of bempikibart offers hope for effective treatment of severe alopecia areata amid unmet medical needs.
Optimizing Atopic Dermatitis Care With Emerging Topical Therapeutics
In a recent Dermatology Times Case-Based Roundtable event, Lisa Swanson, MD, discussed 3 diverse atopic dermatitis patient cases.
Dermatology Conferences and Meetings Calendar: May 2025
Dermatology Times has compiled a list of dermatological meetings taking place during the month of May.
Frequency-Specific Sound Enhances Tissue Regrowth
Acoustic stimulation using infrasound and low-frequency sound enhances wound healing, promoting cellular activity and tissue repair in innovative, non-invasive ways.
Exploring Varying Doses of Oral Isotretinoin for Facial Warts and its Impact on Quality of Life
A new study reveals the effectiveness of two isotretinoin doses for treating recalcitrant facial flat warts, enhancing quality of life and reducing anxiety.
The social media campaign aims to educate, inspire prevention, and support actinic keratosis awareness leading up to Global AK Awareness Day on May 24.
Botulinum Toxin A and Hyaluronic Acid Reduce Acne-Caused Enlarged Pores, New Study Finds
A study reveals that combining botulinum toxin A and hyaluronic acid significantly reduces acne-related enlarged pores, enhancing skin texture and patient satisfaction.
Dermatology’s Carbon Footprint Under the Microscope
Explore the urgent need for sustainability in dermatology, addressing its environmental impact and advocating for eco-friendly practices in health care.
New findings reveal DecisionDx-Melanoma more accurately identifies patients with under 5% risk of SLN positivity, supporting safer avoidance of SLNB surgery.
Exploring the Long-Term Psychosocial Impacts of Stage IV Melanoma in Survivors
Stage IV melanoma survivors face persistent adverse effects and distress, highlighting the need for targeted psychological support and care.
Guselkumab Effective in Real-World Korean Psoriasis Study
Guselkumab shows high effectiveness and safety in treating moderate to severe plaque psoriasis, enhancing quality of life in real-world Korean patients.
OCT and D-OCT Imaging Reveal Distinct Vascular and Dermal Patterns in Skin Photoaging Phenotypes
Collagen structure and vessel density vary by photoaging type, highlighting the value of multimodal imaging in guiding individualized skin care strategies.
Electrotrichogenic Niostem Device Promotes Hair Growth in Men with Androgenetic Alopecia
A novel electrotrichogenic device shows promising results in promoting dense, thickened hair growth for male androgenetic alopecia patients.
Rare Autoimmune Disorder Linked With Increased Risk of Certain Skin Cancers
Patients with mucous membrane pemphigoid face increased skin cancer risks, particularly squamous cell carcinoma, highlighting the need for vigilant screening.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.